It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
Professor Mackay was the first to show that the overproduction of BAFF was driving lupus. In a follow up study, elevated levels of BAFF were discovered in patients with a number of autoimmune diseases including lupus, rheumatoid arthritis and Sjögren’s syndrome.
She said this was an exciting discovery as it implied that if BAFF production can be blocked, the entire cascade effect that resulted in autoimmune disease could be prevented.
Professor Fabienne Mackay Head of the Department of Immunology at Monash University, discovered a new factor in the development of the disease, something known as BAFF - B cell Activating Factor.
It has led directly to the development of a medication called Benlysta, which was approved by the US Food and Drug Authority for release last month.
Manufacturers of the drug, GlaxoSmithKline designed their clinical trials in line with the insights from Professor Mackay’s experimental data.
Originally posted by Maxmars
reply to post by tristar
That's quite alright. I hope the news is well met, and leads to comfort in any way possible.